Close Menu

NEW YORK (GenomeWeb) – NeoGenomics has filed with the US Securities and Exchange Commission for a public offering of approximately $150 million of its common stock, the firm said after the close of the market on Monday.

The company, based in Fort Myers, Florida, said that it plans to use the net proceeds from the offering for general corporate purposes.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.